Advances of MR imaging in glioma: what the neurosurgeon needs to know - Scorecard - MDSpire

Advances of MR imaging in glioma: what the neurosurgeon needs to know

  • By

  • Anna Falk Delgado

  • June 21, 2025

  • 0 min

Share

Clinical Scorecard: Progress in MRI Techniques for Glioma: Essential Insights for Neurosurgeons

At a Glance

CategoryDetail
ConditionHigh-grade gliomas (HGGs), including glioblastoma and molecularly defined glioma subtypes
Key MechanismsTumor infiltration, molecular heterogeneity, neovascularization, altered vascular permeability, and cellular density affecting MRI signals
Target PopulationPatients with suspected or confirmed gliomas, including pediatric and renal-impaired patients
Care SettingNeurosurgical and neuro-oncology clinical settings involving diagnosis, surgical planning, treatment monitoring, and surveillance

Key Highlights

  • MRI is central to glioma care, providing superior soft tissue contrast and advanced physiological imaging techniques.
  • Perfusion MRI techniques (DSC, DCE, ASL) offer insights into tumor vascular physiology and grade, each with distinct advantages and limitations.
  • Diffusion-weighted imaging (DWI) and diffusion tensor imaging (DTI) assess tumor cellularity and white matter tract integrity, aiding surgical planning.

Guideline-Based Recommendations

Diagnosis

  • Use integrated molecular diagnostics alongside MRI for glioma classification per 2021 WHO CNS tumor guidelines.
  • Employ conventional MRI sequences (T1, T2) combined with advanced techniques (perfusion, diffusion, spectroscopy) for tumor characterization.

Management

  • Select perfusion MRI technique based on clinical question, lesion characteristics, and patient factors (e.g., contraindications to gadolinium).
  • Incorporate DTI for white matter tract mapping to guide maximal safe surgical resection.
  • Use MRI findings to stratify patients for treatment planning and clinical trials.

Monitoring & Follow-up

  • Apply perfusion MRI to assess treatment response and detect tumor progression or recurrence.
  • Utilize ASL for longitudinal studies requiring multiple scans without contrast exposure, especially in vulnerable populations.

Risks

  • DSC perfusion MRI is sensitive to susceptibility artifacts and may be inaccurate near hemorrhage, calcification, or surgical materials.
  • DCE perfusion MRI requires complex post-processing and has variable protocols limiting standardization.
  • ASL has lower spatial resolution, is motion sensitive, and may underestimate perfusion in slow flow regions.

Patient & Prescribing Data

Glioma patients including those with contraindications to gadolinium contrast (e.g., renal impairment, pediatric patients).

MRI perfusion and diffusion techniques guide surgical and therapeutic decisions, with non-contrast ASL preferred when gadolinium is contraindicated.

Clinical Best Practices

  • Integrate molecular diagnostics with MRI findings for accurate glioma classification and prognosis.
  • Choose MRI perfusion technique tailored to lesion characteristics and patient safety considerations.
  • Use DTI-based fiber tractography to minimize neurological deficits during surgical resection.
  • Recognize technical limitations of each MRI modality to interpret imaging accurately.
  • Employ advanced MRI techniques for comprehensive tumor assessment throughout treatment continuum.

References

Original Source(s)

Related Content